Impact of Covid-19 on global pharmaceutical production and trade
Drugs & APIs shortage is a global issue with an evident impact affecting all the people independently of their geographic or economic position.
An overview of the US pharma landscape
Over the past 10+ years the pharmaceutical Industry has utilized CDMO’s at an increasing level from year to year never seen prior to this period...
“CRDMO” the new business model for future of the (Bio)Pharma Industry
Today CDMOs face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm...
Angelini Pharma continues its commitment to HPAPI services
Facing the rising number of custom HPAPIs demand, Angelini Fine Chemicals decided to expand its HPAPI capacity at its Aprilia,Italy plant site
Flow Chemistry as novel chirotechnologic tool for asymmetric synthesis of APIs
The continuous-flow enantioselective processes have to be seen as a pivot point for sustainable development of the tomorrow’s pharmaceutical industry
Modern and future strategic trends of the pharma outsourcing market
Today Contract Development Manufacturing Organizations (CDMOs) face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm
Angelini Fine Chemicals increases the production of High Potent Active Pharmaceutical Ingredients
HPAPIs are becoming increasingly central to the world of the pharmaceutical industry.